康泽药业 (831397.OC)

+ 收藏

利润表(康泽药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 357,853,129.111,183,991,089.73903,475,046.572,279,333,742.161,132,784,005.93
 营业收入(元) 357,853,129.111,183,991,089.73903,475,046.572,279,333,742.161,132,784,005.93
二、营业总成本(元) 373,123,033.741,219,644,231.43871,441,630.582,217,031,114.061,081,203,816.71
 营业成本(元) 297,249,187.761,051,646,128.65792,088,312.622,062,456,551.301,003,866,753.60
 营业税金及附加(元) 2,549,276.122,255,291.99837,556.272,349,390.27697,051.48
 销售费用(元) 50,158,376.65113,538,928.0554,962,616.71100,876,688.2949,893,630.35
 管理费用(元) 17,347,302.1037,468,758.8815,867,336.4034,544,622.0218,116,677.58
 财务费用(元) 5,818,891.1114,735,123.867,685,808.5816,803,862.188,629,703.70
  其中:利息费用(元) 5,742,937.8114,988,250.857,675,979.45-7,996,586.81
  其中:利息收入(元) -126,898.531,245,690.41-656,444.33-131,175.19
三、其他经营收益
 加:投资收益(元) -1,767,226.95-1,642,188.21-1,681,204.6617,243,111.57-3,503,709.53
  其中:对联营企业和合营企业的投资收益(元) -----3,862,185.37
 资产处置收益(元) 2,447,029.98104.01-5,456.61-773,762.38-773,748.39
 资产减值损失(元) -357,237.71-527,776.563,458.59-185,343.04-
 信用减值损失(元) -37,393,851.21-10,898,084.16-4,608,964.43-17,257,662.59-8,221,818.78
 其他收益(元) 60,634.35118,774.5160,521.13709,544.94562,555.73
四、营业利润(元) -52,280,556.17-48,602,312.1125,801,770.0162,038,516.6039,643,468.25
 加:营业外收入(元) 357,915.641,432,459.53891,275.091,469,830.77531,020.83
 减:营业外支出(元) 814,929.464,230,929.6299,514.911,858,032.75294,109.88
五、利润总额(元) -52,737,569.99-51,400,782.2026,593,530.1961,650,314.6239,880,379.20
 减:所得税费用(元) -13,838,017.59-3,652,432.785,254,578.2413,254,255.3410,888,582.91
六、净利润(元) -38,899,552.40-47,748,349.4221,338,951.9548,396,059.2828,991,796.29
(一)按经营持续性分类
  持续经营净利润(元) -38,899,552.40-47,748,349.42-48,396,059.28-
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -41,135,896.24-47,425,690.6821,435,219.0248,372,066.1728,991,796.29
  少数股东损益(元) 2,236,343.84-322,658.74-96,267.0723,993.11-
 扣除非经常性损益后的净利润(元) -40,863,680.41-45,701,448.4620,800,100.5048,697,424.5028,971,573.11
七、每股收益
 一、基本每股收益(元) -0.15-0.180.080.180.11
 二、稀释每股收益(元) -0.15-0.180.080.180.11
九、综合收益总额(元) -38,899,552.40-47,748,349.4221,338,951.9548,396,059.2828,991,796.29
 归属于母公司所有者的综合收益总额(元) -41,135,896.24-47,425,690.6821,435,219.0248,372,066.1728,991,796.29
 归属于少数股东的综合收益总额(元) 2,236,343.84-322,658.74-96,267.0723,993.11-
公告日期 2024-08-282024-04-262023-08-252023-04-252022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院